Our previous study demonstrated that the expression of DSC2 in ESCC gradually decreases between regions exhibiting esophageal hyperplasia to regions of dysplasia and carcinoma in situ (14). This evidence concerns the gene DSC2 and esophageal squamous cell carcinoma.